lobbying_activities: 1159029

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1159029	badcedab-d477-4f82-ac6c-a16ead251830	Q3	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2011	third_quarter	PHA	Reauthorization of the Prescription Drug User Fee Act; Drug Safety	HOUSE OF REPRESENTATIVES,SENATE		530000	0	0	2011-10-19T14:34:46.067000-04:00